Literature DB >> 12045968

Use of mitomycin C and 5-fluorouracil in external dacryocystorhinostomy.

Müslime Yalaz1, Enis Firinciogullari, Handan Zeren.   

Abstract

PURPOSE. To evaluate the effects of antiproliferative agents on the fibrous tissue responsible for the failure of external dacryocystorhinostomy at the site of surgical rhinostomy. METHODS. The study group consisted of 60 cases. Patients with primary acquired idiopathic nasolacrimal duct obstruction were divided into three groups according to the agent used. Each group consisted of 20 patients. Mitomycin C was applied to the first group (0.5 mg/ml to 10, 1 mg/ml to 10 cases) and 5-flourouracil to the second group (2.5 mg/ml to 10, 5 mg/ml to 10 cases). The third group consisted of 20 control cases. The mean follow-up period was 15.3 +/- 2.60 (12-18) months. The tissues obtained during the revision of the cases with failure were evaluated by light and electron microscopic examination. RESULTS. External dacryocystorhinostomy failed in four cases. Of these, one was in the first group (0.5 mg/ml mitomycin C), one in the second group (2.5 mg/ml 5-flourouracil), and two were in the control group. Light microscopic examination of the tissues revealed an increase in fibroblastic activity in the control group whereas hypo- and acellular areas were found to be dominant in the groups given antifibroblastic agents. The control group revealed more active fibroblasts with cytoplasms containing numerous organelles in electron microscopic examination. Electron microscopic examination of the cases given antifibroblastic agents revealed fibroblastic cells with nuclear fragmentation, necrosis or pyknosis, while some others had scanty cytoplasms poor in organelles. CONCLUSION. We can conclude that intraoperative antiproliferative agents improve the success rate of external dacryocystorhinostomy.

Entities:  

Year:  1999        PMID: 12045968     DOI: 10.1076/orbi.18.4.239.2686

Source DB:  PubMed          Journal:  Orbit        ISSN: 0167-6830


  6 in total

1.  Success Rate Comparis on of External Dacryocystorhinostomy with 5-FU Application or Silicone Tube Intubation.

Authors:  Ayşe Burcu Dirim; Ibrahim Çağrı Türker; Ceylan Uslu Doğan; Selam Yekta Şendül; Emine Betül Akbaş Özyürek
Journal:  J Ophthalmol       Date:  2022-07-07       Impact factor: 1.974

Review 2.  The clinical applications of fluorouracil in ophthalmic practice.

Authors:  Lekha M Abraham; Dinesh Selva; Robert Casson; Igal Leibovitch
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  Antimetabolites as an adjunct to dacryocystorhinostomy for nasolacrimal duct obstruction.

Authors:  Paul O Phelps; Samuel A Abariga; Benjamin J Cowling; Dinesh Selva; Marcus M Marcet
Journal:  Cochrane Database Syst Rev       Date:  2020-04-07

4.  Long-term results of adjunctive use of mitomycin C in external dacryocystorhinostomy.

Authors:  Cem Yildirim; Volkan Yaylali; Arif Esme; Serap Ozden
Journal:  Int Ophthalmol       Date:  2007-03-22       Impact factor: 2.029

Review 5.  Mitomycin-C in dacryocystorhinostomy: From experimentation to implementation and the road ahead: A review.

Authors:  Akshay Gopinathan Nair; Mohammad Javed Ali
Journal:  Indian J Ophthalmol       Date:  2015-04       Impact factor: 1.848

6.  Intra-Operative Mitomycin-C as Adjuvant Therapy in External and Endonasal Dacryocystorhinostomy: Systematic Review and Meta-Analysis.

Authors:  Tamata T S Sousa; Silvana A Schellini; Roberta L F S Meneghim; Antonio J M Cataneo
Journal:  Ophthalmol Ther       Date:  2020-04-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.